{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T22:28:37Z","timestamp":1770935317403,"version":"3.50.1"},"reference-count":60,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1517\/13543784.10.5.925","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T15:31:58Z","timestamp":1115220718000},"page":"925-934","source":"Crossref","is-referenced-by-count":21,"title":["Advances in experimental treatment of \u03b2-thalassaemia"],"prefix":"10.1517","volume":"10","author":[{"given":"Griffin P","family":"Rodgers","sequence":"first","affiliation":[{"name":"Chief, Molecular and Clinical Hematology Branch, National Institutes of Diabetes, Digestive and Kidney Diseases, Bethesda, MD 20892, USA gprod@helix.nih.gov"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogen","family":"Saunthararajah","sequence":"additional","affiliation":[{"name":"Section of Hematology\/Oncology (MC734), University of Illinois at Chicago, MBRB rm 3150, 900 South Ashland Avenue, Chicago, IL 60607-7173, USA. yogen@uic.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"e_1_2_1_5_1","first-page":"29","article-title":"A series of cases of splenomegaly in children with anemia and peculiar bone changes","volume":"37","author":"COOLEY TB","year":"1925","unstructured":"COOLEY TB, LEE P: A series of cases of splenomegaly in children with anemia and peculiar bone changes. Trans. Am. Pediatr. Soc. (1925) 37:29\u201330.","journal-title":"Trans. Am. Pediatr. Soc."},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(98)80070-X"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200011000-00014"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.15.6728"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00470a019"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1182\/blood.V93.7.2208","article-title":"STAMATOYAN-NOPOULOS: Development of viral vectors for gene therapy of I3-chain hemoglobinopathies: optimization of a y-globin gene expression cassette","volume":"93","author":"LI Q","year":"1999","unstructured":"LI Q, EMERY DW, FERNANDEZ M, HAN H, STAMATOYAN-NOPOULOS: Development of viral vectors for gene therapy of I3-chain hemoglobinopathies: optimization of a y-globin gene expression cassette. Blood (1999) 93:2208\u20132216.","journal-title":"Blood"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.58.12.1026"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198506203122503"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","unstructured":"BRITTENHAM GM GRIFFITH PM ANDNIENHUIS AW et al.: Efficacy of deferox amine in preventing complications of iron overload in patients with thalassemia major. N Engl. J. Med. (1994) 331 (Suppl. 9):567\u2013573.","DOI":"10.1056\/NEJM199409013310902"},{"key":"e_1_2_1_14_1","unstructured":"\u2022\u2022Confirms the substantial impact iron chelation has on thalas-saemia major outcomes."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)90319-1"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704233161703"},{"key":"e_1_2_1_17_1","unstructured":"\u2022\u2022Confirms that transplantation can be considered as atreatment option."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113437"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/264247a0"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90192-8"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(80)90086-0"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.14.4428"},{"key":"e_1_2_1_23_1","unstructured":"\u2022\u2022The beginning of pharmacological strategies to increasefetal haemoglobin levels."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309163291205"},{"key":"e_1_2_1_25_1","unstructured":"\u2022\u2022Suggests potential of methyl-transferase inhibitors intreatment of thalassaemia."},{"key":"e_1_2_1_26_1","first-page":"457","article-title":"DNA m ethyla-tion and globin gene expression in patients treated with 5-azacytidine","volume":"134","author":"LEY TJ","year":"1983","unstructured":"LEY TJ, ANAGNOU NP, NOGUCHI CT et al.: DNA m ethyla-tion and globin gene expression in patients treated with 5-azacytidine. Prog. Clin. Biol. Res. (1983) 134 :457\u2013474.","journal-title":"Prog. Clin. Biol. Res."},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212093072401"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/5.12.1583"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.5.1451"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/6.1.145"},{"key":"e_1_2_1_31_1","first-page":"1800","article-title":"Effect of 5-azacytidine on the progressive nature of cell transformation","volume":"5","author":"HSIAO WL","year":"1985","unstructured":"HSIAO WL, CATTONI-CELLI S, WEINSTEIN IB: Effect of 5-azacytidine on the progressive nature of cell transformation. Mot. Cell. Biol. (1985) 5:1800\u20131803.","journal-title":"Mot. Cell. Biol."},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90329-1"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.9.4681"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.7.2379"},{"key":"e_1_2_1_35_1","unstructured":"\u2022\u2022Indicates potential of 5-AZA-2t-deoxycytidine as an inducerof fetal haemoglobin expression."},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V67.3.735.735"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00719.x"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05584.x"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.1.43.bloodjournal85143"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301143280202"},{"key":"e_1_2_1_41_1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood.V81.2.529.529","article-title":"Fetal hemoglobin induction with butyric acid: efficacy and toxicity","volume":"81","author":"BLAU C A, CONSTANTOULAKIS P, SHAW C M, STAMATOYANNOPOULOS G","year":"1993","unstructured":"BLAU C A, CONSTANTOULAKIS P, SHAW C M, STAMATOYANNOPOULOS G: Fetal hemoglobin induction with butyric acid: efficacy and toxicity. Blood (1993) 81:529\u2013537.","journal-title":"Blood"},{"key":"e_1_2_1_42_1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood.V84.1.339.339","article-title":"Induction offetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate","volume":"84","author":"DOVER G J, BRUSILOW S, CHARACHE S","year":"1994","unstructured":"DOVER G J, BRUSILOW S, CHARACHE S: Induction offetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood (1994) 84:339\u2013343.","journal-title":"Blood"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506153322404"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.10.3357"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63080-2"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.23.13143"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb10470.x"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05156.x"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1159\/000203624"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1997.tb01405.x"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.8.12.2141"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199958030-00021"},{"key":"e_1_2_1_53_1","doi-asserted-by":"crossref","unstructured":"GALANELLO R: Iron chelation: new therapies. Sem. Hematol (2001) 38 (Suppl. 0:73\u201376","DOI":"10.1016\/S0037-1963(01)90063-0"},{"key":"e_1_2_1_54_1","unstructured":"GALANELLO R LOEHRER F ALBERTI D et al.: A novel oraliron chelator (IC1670A): update on a Phase I single dose safety study. 7th Internatinal Conference on Thalas-semia and the Haemaglobinopathies Bangkok Thailand (1999) (Abstract)."},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/5047"},{"key":"e_1_2_1_56_1","unstructured":"\u2022\u2022Link between methylation and histone deacetylation in genesilencing."},{"key":"e_1_2_1_57_1","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1182\/blood.V72.5.1536.1536","article-title":"Butyrate induces selective transcriptional activation of a hypomethy-lated embryonic globin gene in adult erythroid cells","volume":"75","author":"BURNS LJ","year":"1988","unstructured":"BURNS LJ, GLAUBER JG, GINDER GD: Butyrate induces selective transcriptional activation of a hypomethy-lated embryonic globin gene in adult erythroid cells. Blood (1988) 75:1536\u20131542.","journal-title":"Blood"},{"key":"e_1_2_1_58_1","first-page":"1963","article-title":"STAMATOYANNO-POULOS G: On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-azaC and araC","volume":"1989","author":"CONSTANTOULAKIS P","unstructured":"CONSTANTOULAKIS P, KNITTER G, STAMATOYANNO-POULOS G: On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-azaC and araC. Blood (1989) 74: 1963-1971.","journal-title":"Blood"},{"key":"e_1_2_1_59_1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/MCB.15.2.790","article-title":"Effects of butyrate and glucocorticoids on7- to 13-globin gene switching in somatic cell hybrids","volume":"19","author":"ZITNIK G","year":"1995","unstructured":"ZITNIK G, PETERSON G, STAMATOYANNOPOULOS G, PAPAYANNOPOULOU T: Effects of butyrate and glucocorticoids on7- to 13-globin gene switching in somatic cell hybrids. Mol. Cell Biol. (1995) 19:790\u2013795.","journal-title":"Mol. Cell Biol."},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb10465.x"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.1.321"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.6.4182"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506153322404"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00811.x"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.10.5.925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T21:53:05Z","timestamp":1770933185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.10.5.925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1517\/13543784.10.5.925"],"URL":"https:\/\/doi.org\/10.1517\/13543784.10.5.925","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}